These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1755973)

  • 1. Targeting and controlled release of antigens for the effective induction of secretory antibody responses.
    Mestecky J; Eldridge JH
    Curr Opin Immunol; 1991 Aug; 3(4):492-5. PubMed ID: 1755973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunity and strategies for novel microbial vaccines.
    Mestecky J; Moldoveanu Z; Novak M; Compans RW
    Acta Paediatr Jpn; 1994 Oct; 36(5):537-44. PubMed ID: 7825460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern mucosal vaccines, adjuvants and microbicides.
    Cranage MP; Manoussaka M
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):21-3. PubMed ID: 19622054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for human mucosal vaccines.
    Mestecky J; McGhee JR
    Adv Exp Med Biol; 1992; 327():13-23. PubMed ID: 1295333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of local antibody production: parenteral or mucosal vaccination?
    Bouvet JP; Decroix N; Pamonsinlapatham P
    Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins.
    Albu DI; Jones-Trower A; Woron AM; Stellrecht K; Broder CC; Metzger DW
    J Virol; 2003 May; 77(10):5589-97. PubMed ID: 12719551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
    Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
    Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
    Sijun H; Yong X
    Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant.
    Horner AA; Raz E
    Clin Immunol; 2000 Apr; 95(1 Pt 2):S19-29. PubMed ID: 10729234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
    Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
    Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
    Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
    Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR; Mestecky J
    Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity.
    Moldoveanu Z; Huang WQ; Kulhavy R; Pate MS; Mestecky J
    J Immunol; 2005 Sep; 175(6):4127-36. PubMed ID: 16148163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit.
    Oien NL; Brideau RJ; Walsh EE; Wathen MW
    Vaccine; 1994 Jun; 12(8):731-5. PubMed ID: 8091852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucosal immunity].
    van der Heijden PJ; Bianchi AT
    Tijdschr Diergeneeskd; 1990 Nov; 115(22):1058-64. PubMed ID: 2256097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
    Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
    J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.
    Dougan G; Ghaem-Maghami M; Pickard D; Frankel G; Douce G; Clare S; Dunstan S; Simmons C
    Philos Trans R Soc Lond B Biol Sci; 2000 May; 355(1397):705-12. PubMed ID: 10874742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.